Notably, BCAT1 promotes cell proliferation in aggressive gliomas, and BCAT1 inhibition in combination with α-ketoglutarate triggers metabolic synthetic lethality in glioma cells [13, 14]. The gene discussed is BCAT1; the disease is glioma.